This one-hour, journal article–based activity explores key clinical predictors of treatment success for methamphetamine use disorder (MUD) by analyzing secondary data from the landmark ADAPT-2 trial. The article examines how patient levels of craving and impulsivity correlate with transitions between positive and negative urine drug screens (UDS) in individuals receiving a combination of injectable naltrexone and oral bupropion. These findings provide insights for clinicians aiming to optimize pharmacotherapy outcomes and tailor interventions for a high-risk population currently lacking FDA-approved medication options.

This six-module on-demand course provides a comprehensive foundation in the integrated management of pain and addiction.

This 30-minute, on-demand session from the ASAM 2025 Review Course discusses substance-related treatment for pregnant or post-partum patients and newborns.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This 60-minute, on-demand session from the ASAM 2023 Review Course provides an understanding of key principles such as tolerance, dependence, hyperalgesia, pharmacokinetics, and pharmacodynamics while also discussing applications and limitations including interpretation pitfalls of screening and confirmatory urine drug tests.